Drugs / Echinaforce tincture
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04999098 Comparator | Nov 2021 → May 2023 | COVID-19 | A. Vogel AG | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Echinaforce tincture | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04999098 ↗ |
| Route | Other | “Gargling of 2 x 19 drops of Echinaforce tincture (1'200 mg EF) is diluted in 2 x35 mL water” NCT04999098 ↗ |